Tumour lysis syndrome after splenic irradiation in a patient with JAK2 V617F post-polycythaemia vera myelofibrosis. - Suppr | 超能文献

Tumour lysis syndrome after splenic irradiation in a patient with JAK2 V617F post-polycythaemia vera myelofibrosis.

作者信息

Jain S, Harrison C, McMullin M F, Houston R F

出版信息

Clin Oncol (R Coll Radiol). 2010 Dec;22(10):893. doi: 10.1016/j.clon.2010.07.002. Epub 2010 Aug 7.

DOI:10.1016/j.clon.2010.07.002

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Tumour lysis syndrome after splenic irradiation in a patient with JAK2 V617F post-polycythaemia vera myelofibrosis.

Clin Oncol (R Coll Radiol). 2010 Dec;22(10):893. doi: 10.1016/j.clon.2010.07.002. Epub 2010 Aug 7.

2

The disappearance of two alleles of JAK2 V617F from peripheral blood of a polycythaemia vera patient correlates with transformation into myelofibrosis.

Br J Haematol. 2007 Sep;138(6):822-3. doi: 10.1111/j.1365-2141.2007.06743.x.

3

JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.

Haematologica. 2007 Dec;92(12):1717-8. doi: 10.3324/haematol.12011.

4

No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1350-1. doi: 10.1016/j.bbmt.2006.07.010.

5

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.

Eur J Haematol. 2007 Dec;79(6):508-15. doi: 10.1111/j.1600-0609.2007.00960.x. Epub 2007 Oct 23.

6

A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.

Cancer Genet Cytogenet. 2007 Jan 15;172(2):107-12. doi: 10.1016/j.cancergencyto.2006.09.015.

7

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates.

Br J Haematol. 2005 Nov;131(3):320-8. doi: 10.1111/j.1365-2141.2005.05776.x.

8

A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis.

Leukemia. 2007 Jun;21(6):1331-2. doi: 10.1038/sj.leu.2404649. Epub 2007 Mar 15.

9

JAK2-positive Philadelphia-negative myeloproliferative neoplasms.

Indian J Pathol Microbiol. 2011 Jan-Mar;54(1):117-20. doi: 10.4103/0377-4929.77355.

10

The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.

Clin Adv Hematol Oncol. 2009 May;7(5):334-42.

引用本文的文献

1

Palliative Radiotherapy Induced Severe Tumor Lysis Syndrome in a Patient With Multiple Myeloma With Skin Involvement: A Case Report and Review of Literature.

Cancer Diagn Progn. 2023 Mar 3;3(2):257-263. doi: 10.21873/cdp.10210. eCollection 2023 Mar-Apr.

2

Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis.

Intern Med. 2017 Sep 1;56(17):2335-2338. doi: 10.2169/internalmedicine.8706-16. Epub 2017 Aug 10.